X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NBIX

Closed

Neurocrine Biosciences Inc

128.
+2 (+1.59%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 125.69
Day's Range: 126.15 - 129.27
Send
When Written:
 
104.77
Neurocrine Biosciences Inc. is a biopharmaceutical company that specializes in developing treatments for neurological, endocrine, and psychiatric disorders. The company was founded in 1992 and is headquartered in San Diego, California.

Neurocrine Biosciences has several products on the market, including Ingrezza (valbenazine) for the treatment of tardive dyskinesia and Ongentys (opicapone) for Parkinson's disease. The company also has several products in clinical development, including treatments for schizophrenia, depression, and rare genetic disorders.

Neurocrine Biosciences has partnerships with several other pharmaceutical companies, including AbbVie, Takeda, and Janssen. The company's mission is to improve the lives of patients suffering from neurological and endocrine disorders through innovative research and development.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X